These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8617181

  • 61. Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study.
    Mattia D, Spanedda F, Bassetti MA, Romigi A, Placidi F, Marciani MG.
    Clin Neurophysiol; 2000 Feb; 111(2):311-7. PubMed ID: 10680567
    [Abstract] [Full Text] [Related]

  • 62. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA, American Academy of Neurology Therapeutics and Technology Assessment Subcommittee, American Academy of Neurology Quality Standards Subcommittee, American Epilepsy Society Therapeutics and Technology Assessment Subcommittee, American Epilepsy Society Quality Standards Subcommittee.
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [Abstract] [Full Text] [Related]

  • 63. Double-blind study of Gabapentin in the treatment of partial seizures.
    Sivenius J, Kälviäinen R, Ylinen A, Riekkinen P.
    Epilepsia; 1991 May; 32(4):539-42. PubMed ID: 1907907
    [Abstract] [Full Text] [Related]

  • 64. Newer antiepileptic drugs: gabapentin, lamotrigine, felbamate, topiramate and fosphenytoin.
    Curry WJ, Kulling DL.
    Am Fam Physician; 1998 Feb 01; 57(3):513-20. PubMed ID: 9475899
    [Abstract] [Full Text] [Related]

  • 65. Gabapentin: pharmacokinetics, efficacy, and safety.
    Beydoun A, Uthman BM, Sackellares JC.
    Clin Neuropharmacol; 1995 Dec 01; 18(6):469-81. PubMed ID: 8681309
    [Abstract] [Full Text] [Related]

  • 66. Anticonvulsant activity of PNU-151774E in the amygdala kindled model of complex partial seizures.
    Maj R, Fariello RG, Pevarello P, Varasi M, McArthur RA, Salvati P.
    Epilepsia; 1999 Nov 01; 40(11):1523-8. PubMed ID: 10565578
    [Abstract] [Full Text] [Related]

  • 67. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group.
    Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B.
    Epilepsia; 1994 Nov 01; 35(4):795-801. PubMed ID: 8082624
    [Abstract] [Full Text] [Related]

  • 68. Increased seizures after discontinuing carbamazepine: results from the gabapentin monotherapy trial.
    DeToledo JC, Ramsay RE, Lowe MR, Greiner M, Garofalo EA.
    Ther Drug Monit; 2000 Dec 01; 22(6):753-6. PubMed ID: 11128246
    [Abstract] [Full Text] [Related]

  • 69. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials.
    Leiderman DB.
    Epilepsia; 1994 Dec 01; 35 Suppl 5():S74-6. PubMed ID: 8039475
    [Abstract] [Full Text] [Related]

  • 70. Gabapentin-induced mood changes with hypomanic features in adults.
    Trinka E, Niedermüller U, Thaler C, Doering S, Moroder T, Ladurner G, Bauer G.
    Seizure; 2000 Oct 01; 9(7):505-8. PubMed ID: 11034877
    [Abstract] [Full Text] [Related]

  • 71. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE.
    Epilepsia; 1994 Oct 01; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [Abstract] [Full Text] [Related]

  • 72. Gabapentin as adjunctive therapy for partial seizures.
    Bruni J.
    Epilepsia; 1999 Oct 01; 40 Suppl 6():S27-8; discussion S73-4. PubMed ID: 10530680
    [Abstract] [Full Text] [Related]

  • 73. Rapid initiation of gabapentin: a randomized, controlled trial.
    Fisher RS, Sachdeo RC, Pellock J, Penovich PE, Magnus L, Bernstein P.
    Neurology; 2001 Mar 27; 56(6):743-8. PubMed ID: 11274308
    [Abstract] [Full Text] [Related]

  • 74. Catatonia following gabapentin withdrawal.
    Rosebush PI, MacQueen GM, Mazurek MF.
    J Clin Psychopharmacol; 1999 Apr 27; 19(2):188-9. PubMed ID: 10211925
    [No Abstract] [Full Text] [Related]

  • 75. Gabapentin-induced bullous pemphigoid.
    Zachariae CO.
    Acta Derm Venereol; 2002 Apr 27; 82(5):396-7. PubMed ID: 12430752
    [No Abstract] [Full Text] [Related]

  • 76. Rebound psychiatric and physical symptoms after gabapentin discontinuation.
    Corá-Locatelli G, Greenberg BD, Martin JD, Murphy DL.
    J Clin Psychiatry; 1998 Mar 27; 59(3):131. PubMed ID: 9541157
    [No Abstract] [Full Text] [Related]

  • 77. Gabapentin treatment of seizures in acute intermittent porphyria.
    Tatum WO, Zachariah SB.
    Neurology; 1995 Jun 27; 45(6):1216-7. PubMed ID: 7783893
    [Abstract] [Full Text] [Related]

  • 78. Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis.
    Borowicz KK, Swiader M, Luszczki J, Czuczwar SJ.
    Epilepsia; 2002 Sep 27; 43(9):956-63. PubMed ID: 12199720
    [Abstract] [Full Text] [Related]

  • 79. A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England.
    Wilton LV, Shakir S.
    Epilepsia; 2002 Sep 27; 43(9):983-92. PubMed ID: 12199723
    [Abstract] [Full Text] [Related]

  • 80. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients.
    Solaro C, Lunardi GL, Capello E, Inglese M, Messmer Uccelli M, Uccelli A, Mancardi GL.
    Neurology; 1998 Aug 27; 51(2):609-11. PubMed ID: 9710049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.